1887

Abstract

The presence of pathogenic prion protein (PrP) in lymphoid tissues of variant Creutzfeldt–Jakob disease (vCJD) patients raises questions as to whether prions may be present in bodily fluids as well. Currently, transgenic mice are highly sensitive tools for the study of prions in tissues or fluids containing high levels of normal prion protein (PrP). We report here an assay with virtually equivalent sensitivity incorporating a capture antibody into a sandwich conformation-dependent immunoassay (CDI), resulting in 30- to 100-fold increased sensitivity compared with the original, direct CDI. Furthermore, spiking plasma with vCJD prions in different preparations demonstrated that sandwich CDI detects prions with different biophysical properties at high sensitivity, even without proteinase K pretreatment of samples. Thus, sandwich CDI represents a powerful tool to study prions in bodily fluids of CJD/vCJD patients, with a turnaround time of less than 24 h.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18996-0
2003-07-01
2020-02-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/7/vir841921.html?itemId=/content/journal/jgv/10.1099/vir.0.18996-0&mimeType=html&fmt=ahah

References

  1. Baron H., Prusiner S. B.. 2000; Prion diseases. In Biological Safety – Principles and Practices , 3rd edn. pp 187–208 Edited by Fleming D. O., Hunt D. L.. Washington: American Society for Microbiology;
    [Google Scholar]
  2. Bolton D. C., Bendheim P. E., Marmorstein A. D., Potempska A.. 1987; Isolation and structural studies of the intact scrapie agent protein. Arch Biochem Biophys258:579–590
    [Google Scholar]
  3. Brown P., Gibbs C. J. Jr, Rodgers-Johnson P., Asher D. M., Sulima M. P., Bacote A., Goldfarb L. G., Gajdusek D. C.. 1994; Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol35:513–529
    [Google Scholar]
  4. Brown P., Rohwer R. G., Dunstan B. C., MacAuley C., Gajdusek D. C., Drohan W. N.. 1998; The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion38:810–816
    [Google Scholar]
  5. Brown P., Cervenakova L., Diringer H.. 2001; Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt–Jakob disease. J Lab Clin Med137:5–13
    [Google Scholar]
  6. Bruce M. E., McConnell I., Will R. G., Ironside J. W.. 2001; Detection of variant Creutzfeldt–Jakob disease infectivity in extraneural tissues. Lancet358:208–209
    [Google Scholar]
  7. Cervenakova L.. 2001; The safety of human blood: experimental TSE/prion infectivity studies. Transfus Clin Biol8:260
    [Google Scholar]
  8. Hill A. F., Zeidler M., Ironside J., Collinge J.. 1997; Diagnosis of new variant Creutzfeldt–Jakob disease by tonsil biopsy. Lancet349:99–100
    [Google Scholar]
  9. Houston F., Foster J. D., Chong A., Hunter N., Bostock C. J.. 2000; Transmission of BSE by blood transfusion in sheep. Lancet356:999–1000
    [Google Scholar]
  10. Hunter N., Foster J., Chong A., McCutcheon S., Parnham D., Eaton S., MacKenzie C., Houston F.. 2002; Transmission of prion diseases by blood transfusion. J Gen Virol83:2897–2905
    [Google Scholar]
  11. Li R., Liu T., Wong B. S.. 7 other authors 2000; Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol301:567–573
    [Google Scholar]
  12. Minor P.. others 2000; Working group on international reference materials for diagnosis and study of transmissible spongiform encephalopathies (TSEs): second meeting.
    [Google Scholar]
  13. Peters J. H., Baumgarten H., Schulze M.. 1985; Monoklonale Antikörper: Herstellung und Charakterisierung Berlin: Springer-Verlag;
    [Google Scholar]
  14. Safar J.. 2003; Conformation-dependent immunoassays: an update. Abstract of presentation given at Cambridge Healthtech Institute's Ninth Annual Transmissible Spongiform Encephalopathies Conference , 12–13 February 2003. Washington, DC:
  15. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F. E., Prusiner S. B.. 1998; Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med4:1157–1165
    [Google Scholar]
  16. Safar J. G., Scott M., Monaghan J.. 12 other authors 2002; Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol20:1147–1150
    [Google Scholar]
  17. Shaked G. M., Shaked Y., Kariv-Inbal Z., Halimi M., Avraham I., Gabizon R.. 2001; A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. J Biol Chem276:31479–31482
    [Google Scholar]
  18. Vey M., Baron H., Weimer T., Gröner A.. 2002; Purity of spiking agent affects partitioning of prions in plasma protein purification. Biologicals30:187–196
    [Google Scholar]
  19. Wadsworth J. D., Joiner S., Hill A. F., Campbell T. A., Desbruslais M., Luthert P. J., Collinge J.. 2001; Tissue distribution of protease resistant prion protein in variant Creutzfeldt–Jakob disease using a highly sensitive immunoblotting assay. Lancet358:171–180
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18996-0
Loading
/content/journal/jgv/10.1099/vir.0.18996-0
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error